Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Phylogenetic Analysis of Trypanosoma cruzi from Pregnant Women and Newborns from Argentina, Honduras, and Mexico Suggests an Association of Parasite Haplotypes with Congenital Transmission of the Parasite.

Herrera C, Truyens C, Dumonteil E, Alger J, Sosa-Estani S, Cafferata ML, Gibbons L, Ciganda A, Matute ML, Zuniga C, Carlier Y, Buekens P.

J Mol Diagn. 2019 Nov;21(6):1095-1105. doi: 10.1016/j.jmoldx.2019.07.004. Epub 2019 Aug 23.

PMID:
31450011
2.

Response to `letter to the editor: 'Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America'´.

Alonso-Padilla J, Cortés-Serra N, Pinazo MJ, Bottazzi ME, Abril M, Barreira F, Sosa-Estani S, Hotez PJ, Gascón J.

Expert Rev Anti Infect Ther. 2019 Sep;17(9):673-675. doi: 10.1080/14787210.2019.1649139. Epub 2019 Aug 6. No abstract available.

PMID:
31361163
3.

Determination of Benznidazole in Human Dried Blood Spots by Liquid Chromatography-Mass Spectrometry to Monitor Adherence to Trypanosoma cruzi Infection Treatment in Infants and Children.

Momper JD, Hanan NJ, Rossi SS, Mirochnick MH, Cafferata ML, Lavenia A, Flores I, Gibbons L, Ciganda A, Sosa Estani S, Capparelli EV, Buekens P.

Am J Trop Med Hyg. 2019 Jul;101(1):116-122. doi: 10.4269/ajtmh.18-0852.

PMID:
31115303
4.

[Congenital transmission of Trypanosoma cruzi. Argentina 2002-2014].

Danesi E, Codebó MO, Sosa-Estani S.

Medicina (B Aires). 2019;79(2):81-89. Spanish.

5.

Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America.

Alonso-Padilla J, Cortés-Serra N, Pinazo MJ, Bottazzi ME, Abril M, Barreira F, Sosa-Estani S, Hotez PJ, Gascón J.

Expert Rev Anti Infect Ther. 2019 Mar;17(3):145-157. doi: 10.1080/14787210.2019.1577731. Epub 2019 Feb 13. Review.

PMID:
30712412
6.

Effects of Trypanocidal Treatment on Echocardiographic Parameters in Chagas Cardiomyopathy and Prognostic Value of Wall Motion Score Index: A BENEFIT Trial Echocardiographic Substudy.

Schmidt A, Dias Romano MM, Marin-Neto JA, Rao-Melacini P, Rassi A Jr, Mattos A, Avezum Á Jr, Villena E, Sosa-Estani S, Bonilla R, Yusuf S, Morillo CA, Maciel BC; BENEFIT Investigators.

J Am Soc Echocardiogr. 2019 Feb;32(2):286-295.e3. doi: 10.1016/j.echo.2018.09.006. Epub 2018 Nov 9.

PMID:
30420161
7.

The burden of congenital Chagas disease and implementation of molecular diagnostic tools in Latin America.

Picado A, Cruz I, Redard-Jacot M, Schijman AG, Torrico F, Sosa-Estani S, Katz Z, Ndung'u JM.

BMJ Glob Health. 2018 Oct 11;3(5):e001069. doi: 10.1136/bmjgh-2018-001069. eCollection 2018.

8.

Clinical and pharmacological profile of benznidazole for treatment of Chagas disease.

Kratz JM, Garcia Bournissen F, Forsyth CJ, Sosa-Estani S.

Expert Rev Clin Pharmacol. 2018 Oct;11(10):943-957. doi: 10.1080/17512433.2018.1509704. Epub 2018 Sep 19. Review.

PMID:
30111183
9.

Course of serological tests in treated subjects with chronic Trypanosoma cruzi infection: A systematic review and meta-analysis of individual participant data.

Sguassero Y, Roberts KN, Harvey GB, Comandé D, Ciapponi A, Cuesta CB, Aguiar C, Castro AM, Danesi E, de Andrade AL, de Lana M, Escribà JM, Fabbro DL, Fernandes CD, Flores-Chávez M, Hasslocher-Moreno AM, Jackson Y, Lacunza CD, Machado-de-Assis GF, Maldonado M, Meira WSF, Molina I, Monje-Rumi MM, Muñoz-San Martín C, Murcia L, Nery de Castro C, Sánchez Negrette O, Segovia M, Silveira CAN, Solari A, Steindel M, Streiger ML, Vera de Bilbao N, Zulantay I, Sosa-Estani S.

Int J Infect Dis. 2018 Aug;73:93-101. doi: 10.1016/j.ijid.2018.05.019. Epub 2018 Jun 4. Review.

10.

Congenital Transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: An Observational Prospective Study.

Buekens P, Cafferata ML, Alger J, Althabe F, Belizán JM, Bustamante N, Carlier Y, Ciganda A, Del Cid JH, Dumonteil E, Gamboa-León R, García JA, Gibbons L, Graiff O, Maldonado JG, Herrera C, Howard E, Lara LS, López B, Matute ML, Ramírez-Sierra MJ, Robles MC, Sosa-Estani S, Truyens C, Valladares C, Wesson DM, Zúniga C, For The Congenital Chagas Working Group.

Am J Trop Med Hyg. 2018 Feb;98(2):478-485. doi: 10.4269/ajtmh.17-0516. Epub 2017 Nov 30.

11.

Comparative Study and Analytical Verification of PCR Methods for the Diagnosis of Congenital Chagas Disease.

Cura CI, Ramírez JC, Rodríguez M, Lopez-Albízu C, Irazu L, Scollo K, Sosa-Estani S.

J Mol Diagn. 2017 Sep;19(5):673-681. doi: 10.1016/j.jmoldx.2017.05.010. Epub 2017 Jul 17.

PMID:
28727985
12.

Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.

Morillo CA, Waskin H, Sosa-Estani S, Del Carmen Bangher M, Cuneo C, Milesi R, Mallagray M, Apt W, Beloscar J, Gascon J, Molina I, Echeverria LE, Colombo H, Perez-Molina JA, Wyss F, Meeks B, Bonilla LR, Gao P, Wei B, McCarthy M, Yusuf S; STOP-CHAGAS Investigators.

J Am Coll Cardiol. 2017 Feb 28;69(8):939-947. doi: 10.1016/j.jacc.2016.12.023.

13.

Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study.

Colantonio LD, Prado N, Segura EL, Sosa-Estani S.

PLoS Negl Trop Dis. 2016 May 9;10(5):e0004651. doi: 10.1371/journal.pntd.0004651. eCollection 2016 May.

14.

New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients.

Álvarez MG, Hernández Y, Bertocchi G, Fernández M, Lococo B, Ramírez JC, Cura C, Albizu CL, Schijman A, Abril M, Sosa-Estani S, Viotti R.

Antimicrob Agents Chemother. 2015 Nov 23;60(2):833-7. doi: 10.1128/AAC.00745-15. Print 2016 Feb.

15.

Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.

Sguassero Y, Cuesta CB, Roberts KN, Hicks E, Comandé D, Ciapponi A, Sosa-Estani S.

PLoS One. 2015 Oct 5;10(10):e0139363. doi: 10.1371/journal.pone.0139363. eCollection 2015. Review.

16.

Text message interventions for follow up of infants born to mothers positive for Chagas disease in Tucumán, Argentina: a feasibility study.

Cormick G, Ciganda A, Cafferata ML, Ripple MJ, Sosa-Estani S, Buekens P, Belizán JM, Althabe F.

BMC Res Notes. 2015 Sep 29;8:508. doi: 10.1186/s13104-015-1498-9.

17.

[Guiding the etiological treatment of Chagas disease].

Sosa Estani S, Altcheh J, Riarte A, Freilij H, Fernandez M, Lloveras S, Pereiro A, Castellano LG, Salvatella R, Nicholls RS; Grupo de Trabajo.

Medicina (B Aires). 2015;75(4):270-1. Spanish. No abstract available.

18.

Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.

Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A Jr, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velazquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S; BENEFIT Investigators.

N Engl J Med. 2015 Oct;373(14):1295-306. doi: 10.1056/NEJMoa1507574. Epub 2015 Sep 1.

19.

Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients.

Ramírez JC, Cura CI, da Cruz Moreira O, Lages-Silva E, Juiz N, Velázquez E, Ramírez JD, Alberti A, Pavia P, Flores-Chávez MD, Muñoz-Calderón A, Pérez-Morales D, Santalla J, Marcos da Matta Guedes P, Peneau J, Marcet P, Padilla C, Cruz-Robles D, Valencia E, Crisante GE, Greif G, Zulantay I, Costales JA, Alvarez-Martínez M, Martínez NE, Villarroel R, Villarroel S, Sánchez Z, Bisio M, Parrado R, Maria da Cunha Galvão L, Jácome da Câmara AC, Espinoza B, Alarcón de Noya B, Puerta C, Riarte A, Diosque P, Sosa-Estani S, Guhl F, Ribeiro I, Aznar C, Britto C, Yadón ZE, Schijman AG.

J Mol Diagn. 2015 Sep;17(5):605-15. doi: 10.1016/j.jmoldx.2015.04.010.

20.

Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment.

Porrás AI, Yadon ZE, Altcheh J, Britto C, Chaves GC, Flevaud L, Martins-Filho OA, Ribeiro I, Schijman AG, Shikanai-Yasuda MA, Sosa-Estani S, Stobbaerts E, Zicker F.

PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003697. doi: 10.1371/journal.pntd.0003697. eCollection 2015 Jun. No abstract available.

21.

Integrated control of Chagas disease for its elimination as public health problem--a review.

Sosa-Estani S, Segura EL.

Mem Inst Oswaldo Cruz. 2015 May;110(3):289-98. doi: 10.1590/0074-02760140408.

22.

Congenital Chagas disease: an update.

Carlier Y, Sosa-Estani S, Luquetti AO, Buekens P.

Mem Inst Oswaldo Cruz. 2015 May;110(3):363-8. doi: 10.1590/0074-02760140405. Epub 2015 Mar 6. Review.

23.

Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas.

Fabbro DL, Danesi E, Olivera V, Codebó MO, Denner S, Heredia C, Streiger M, Sosa-Estani S.

PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3312. doi: 10.1371/journal.pntd.0003312. eCollection 2014 Nov.

24.

Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review.

Pinazo MJ, Thomas MC, Bua J, Perrone A, Schijman AG, Viotti RJ, Ramsey JM, Ribeiro I, Sosa-Estani S, López MC, Gascon J.

Expert Rev Anti Infect Ther. 2014 Apr;12(4):479-96. doi: 10.1586/14787210.2014.899150. Review.

PMID:
24621252
25.

Cultural barriers to effective communication between Indigenous communities and health care providers in Northern Argentina: an anthropological contribution to Chagas disease prevention and control.

Dell'Arciprete A, Braunstein J, Touris C, Dinardi G, Llovet I, Sosa-Estani S.

Int J Equity Health. 2014 Jan 29;13:6. doi: 10.1186/1475-9276-13-6.

26.

Towards a paradigm shift in the treatment of chronic Chagas disease.

Viotti R, Alarcón de Noya B, Araujo-Jorge T, Grijalva MJ, Guhl F, López MC, Ramsey JM, Ribeiro I, Schijman AG, Sosa-Estani S, Torrico F, Gascon J; Latin American Network for Chagas Disease, NHEPACHA.

Antimicrob Agents Chemother. 2014;58(2):635-9. doi: 10.1128/AAC.01662-13. Epub 2013 Nov 18.

27.

Congenital transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: study protocol.

Buekens P, Cafferata ML, Alger J, Althabe F, Belizán JM, Carlier Y, Ciganda A, Dumonteil E, Gamboa-Leon R, Howard E, Matute ML, Sosa-Estani S, Truyens C, Wesson D, Zuniga C.

Reprod Health. 2013 Oct 11;10:55. doi: 10.1186/1742-4755-10-55.

28.

Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis.

Howard EJ, Xiong X, Carlier Y, Sosa-Estani S, Buekens P.

BJOG. 2014 Jan;121(1):22-33. doi: 10.1111/1471-0528.12396. Epub 2013 Aug 7. Review.

29.

Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial.

Moreira OC, Ramírez JD, Velázquez E, Melo MF, Lima-Ferreira C, Guhl F, Sosa-Estani S, Marin-Neto JA, Morillo CA, Britto C.

Acta Trop. 2013 Jan;125(1):23-31. doi: 10.1016/j.actatropica.2012.08.020. Epub 2012 Sep 12.

30.

Therapy of chagas disease: implications for levels of prevention.

Sosa-Estani S, Colantonio L, Segura EL.

J Trop Med. 2012;2012:292138. doi: 10.1155/2012/292138. Epub 2012 Mar 5.

31.

Trypanosoma cruzi discrete typing units in Chagas disease patients from endemic and non-endemic regions of Argentina.

Cura CI, Lucero RH, Bisio M, Oshiro E, Formichelli LB, Burgos JM, Lejona S, Brusés BL, Hernández DO, Severini GV, Velazquez E, Duffy T, Anchart E, Lattes R, Altcheh J, Freilij H, Diez M, Nagel C, Vigliano C, Favaloro L, Favaloro RR, Merino DE, Sosa-Estani S, Schijman AG.

Parasitology. 2012 Apr;139(4):516-21. doi: 10.1017/S0031182011002186. Epub 2012 Feb 6.

PMID:
22309735
32.

Congenital Chagas disease: recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women.

Carlier Y, Torrico F, Sosa-Estani S, Russomando G, Luquetti A, Freilij H, Albajar Vinas P.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1250. doi: 10.1371/journal.pntd.0001250. Epub 2011 Oct 25. Review. No abstract available.

33.

Do commercial serologic tests for Trypanosoma cruzi infection detect Mexican strains in women and newborns?

Gamboa-León R, Gonzalez-Ramirez C, Padilla-Raygoza N, Sosa-Estani S, Caamal-Kantun A, Buekens P, Dumonteil E.

J Parasitol. 2011 Apr;97(2):338-43. doi: 10.1645/GE-2545.1. Epub 2010 Oct 21.

34.

International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.

Schijman AG, Bisio M, Orellana L, Sued M, Duffy T, Mejia Jaramillo AM, Cura C, Auter F, Veron V, Qvarnstrom Y, Deborggraeve S, Hijar G, Zulantay I, Lucero RH, Velazquez E, Tellez T, Sanchez Leon Z, Galvão L, Nolder D, Monje Rumi M, Levi JE, Ramirez JD, Zorrilla P, Flores M, Jercic MI, Crisante G, Añez N, De Castro AM, Gonzalez CI, Acosta Viana K, Yachelini P, Torrico F, Robello C, Diosque P, Triana Chavez O, Aznar C, Russomando G, Büscher P, Assal A, Guhl F, Sosa Estani S, DaSilva A, Britto C, Luquetti A, Ladzins J.

PLoS Negl Trop Dis. 2011 Jan 11;5(1):e931. doi: 10.1371/journal.pntd.0000931.

35.

HIV/STI co-infections, syphilis incidence, and hepatitis B vaccination: the Buenos Aires cohort of men who have sex with men.

Segura M, Bautista CT, Marone R, Sosa Estani S, Rey J, Montano SM, Griemberg G, Weissenbacher M, Avila MM.

AIDS Care. 2010 Dec;22(12):1459-65. doi: 10.1080/09540121003758556.

PMID:
21154033
36.

Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: can injectors be a bridge?

Caiaffa WT, Zocratto KF, Osimani ML, Martínez PL, Radulich G, Latorre L, Muzzio E, Segura M, Chiparelli H, Russi J, Rey J, Vazquez E, Cuchi P, Sosa-Estani S, Rossi D, Weissenbacher M.

Addiction. 2011 Jan;106(1):143-51. doi: 10.1111/j.1360-0443.2010.03118.x. Epub 2010 Oct 19.

PMID:
20955486
37.

Early diagnosis of congenital Trypanosoma cruzi infection, using shed acute phase antigen, in Ushuaia, Tierra del Fuego, Argentina.

Mallimaci MC, Sosa-Estani S, Russomando G, Sanchez Z, Sijvarger C, Alvarez IM, Barrionuevo L, Lopez C, Segura EL.

Am J Trop Med Hyg. 2010 Jan;82(1):55-9. doi: 10.4269/ajtmh.2010.09-0219.

38.

Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission.

Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL.

Rev Soc Bras Med Trop. 2009 Sep-Oct;42(5):484-7.

39.

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease.

Marin-Neto JA, Rassi A Jr, Avezum A Jr, Mattos AC, Rassi A, Morillo CA, Sosa-Estani S, Yusuf S; BENEFIT Investigators.

Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:319-24. Erratum in: Mem Inst Oswaldo Cruz. 2009 Sep;104(6):937. Morillo, Carlos A [added]; Sosa-Estani, Sergio [added]; Yusuf, Salim [added]; BENEFIT Investigators [added].

40.

Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina.

Sosa-Estani S, Viotti R, Segura EL.

Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:167-80. Review.

41.

[Vectorial and congenital transmission of Trypanosoma cruzi in Las Lomitas, Formosa].

Sosa-Estani S, Dri L, Touris C, Abalde S, Dell'arciprete A, Braunstein J.

Medicina (B Aires). 2009;69(4):424-30. Spanish.

PMID:
19770096
42.

Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras, and Mexico.

Sosa-Estani S, Gamboa-León MR, Del Cid-Lemus J, Althabe F, Alger J, Almendares O, Cafferata ML, Chippaux JP, Dumonteil E, Gibbons L, Padilla-Raygoza N, Schneider D, Belizán JM, Buekens P; Working Group.

Am J Trop Med Hyg. 2008 Nov;79(5):755-9.

PMID:
18981518
43.

[Canine brucellosis in dogs in the city of Buenos Aires].

Boeri E, Escobar GI, Ayala SM, Sosa-Estani S, Lucero NE.

Medicina (B Aires). 2008;68(4):291-7. Spanish.

PMID:
18786885
44.

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S; BENEFIT Investigators.

Am Heart J. 2008 Jul;156(1):37-43. doi: 10.1016/j.ahj.2008.04.001.

PMID:
18585495
45.

Multiple infections and associated risk factors among non-injecting cocaine users in Argentina.

Rossi D, Radulich G, Muzzio E, Naveira J, Sosa-Estani S, Rey J, Griemberg G, Friedman SR, Martínez-Peralta L, Weissenbacher M.

Cad Saude Publica. 2008 May;24(5):965-74.

46.

Risk factors for sporadic Shiga toxin-producing Escherichia coli infections in children, Argentina.

Rivas M, Sosa-Estani S, Rangel J, Caletti MG, Vallés P, Roldán CD, Balbi L, Marsano de Mollar MC, Amoedo D, Miliwebsky E, Chinen I, Hoekstra RM, Mead P, Griffin PM.

Emerg Infect Dis. 2008 May;14(5):763-71. doi: 10.3201/eid1405.071050.

47.

Buenos Aires cohort of men who have sex with men: prevalence, incidence, risk factors, and molecular genotyping of HIV type 1.

Segura M, Sosa Estani S, Marone R, Bautista CT, Pando MA, Eyzaguirre L, Sánchez JL, Carr JK, Montano SM, Weissenbacher M, Avila MM.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1322-9. doi: 10.1089/aid.2007.0063.

PMID:
18184073
48.

Tegumentary leishmaniasis outbreak in Bella Vista City, Corrientes, Argentina during 2003.

Salomón OD, Sosa-Estani S, Ramos K, Orellano PW, Sanguesa G, Fernández G, Sinagra A, Rapasciolli G.

Mem Inst Oswaldo Cruz. 2006 Nov;101(7):767-74.

49.

Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina.

Sosa-Estani S, Segura EL.

Curr Opin Infect Dis. 2006 Dec;19(6):583-7. Review.

PMID:
17075335
50.

Detection and characterization of Shiga toxin-producing Escherichia coli in captive non-domestic mammals.

Leotta GA, Deza N, Origlia J, Toma C, Chinen I, Miliwebsky E, Iyoda S, Sosa-Estani S, Rivas M.

Vet Microbiol. 2006 Nov 26;118(1-2):151-7. Epub 2006 Aug 21.

PMID:
16919898

Supplemental Content

Loading ...
Support Center